|1.||Yang, Xiaodong: 1 article (08/2007)|
|2.||Nudelman, Abraham: 1 article (08/2007)|
|3.||Entin-Meer, Michal: 1 article (08/2007)|
|4.||Rephaeli, Ada: 1 article (08/2007)|
|5.||Nudelman, Ayelet: 1 article (08/2007)|
|6.||Haas-Kogan, Daphne Adele: 1 article (08/2007)|
08/18/2007 - "Enthusiasm is lent to this approach by the ability of AN-113 to efficiently kill glioma cells, its bioavailability and potency when administered orally, its capacity to cross the blood-brain barrier, and its effectiveness in combination with radiation."
08/18/2007 - "The precursor of AN-113, 4-phenylbutyrate has shown promising results in a Phase I study of gliomas, and we hypothesized that AN-113 offers significant advantages over the parent drug. "
08/18/2007 - "AN-113, a novel prodrug of 4-phenylbutyrate with increased anti-neoplastic activity in glioma cell lines."
|1.||4-phenylbutyric acid (Buphenyl)